Low-dose methotrexate in PAH related to T-cell large granular lymphocyte leukaemia

European Respiratory Journal

Volumn 39, Issue 2, 2012, Pages 493-494

  Grossi, O ^a,b   Horeau Langlard, D ^c   Agard, C ^a   Haloun, A ^c   Lefebvre, M ^a   Neel, A ^a   Hamidou, M A ^a  

^a HÔTEL DIEU   (France)

^b Nouvelles Cliniques Nantaises   (France)

^c CHU de Nantes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; DOBUTAMINE; FAS ANTIGEN; METHOTREXATE; PROSTACYCLIN;

ADULT; BLOOD CELL COUNT; CASE REPORT; CLINICAL EXAMINATION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG DOSE INCREASE; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOLYTIC ANEMIA; HUMAN; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; LETTER; NATURAL KILLER CELL; OXYGEN THERAPY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PULMONARY HYPERTENSION; T CELL LEUKEMIA; TRANSTHORACIC ECHOCARDIOGRAPHY;

FEMALE; HUMANS; HYPERTENSION, PULMONARY; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; METHOTREXATE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84856708006     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00014811     Document Type: Letter

References (9)

1. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54: Suppl. 1, S43-S54.
2. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392. (Pubitemid 24273002)
3. Lamy T, Loughran TP. How I treat LGL leukemia. Blood 2011; 117: 2764-2774.
4. Lamy T, Bauer FA, Liu JH, et al. Clinicopathological features of aggressive LGL leukaemia resemble Fas ligand transgenic mice. Br J Haematol 2000; 108: 17-23.
5. Chen X, Bai F, Sokol L. A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia. Blood 2009; 113: 3226-3234.
6. Epling-Burnette PK, Sokol L, Chen X, et al. Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signalling. Blood 2008; 112: 4694-4698.
7. Rossof LJ, Genovese J, Coleman M, et al. Primary pulmonary hypertension in a patient with CD8/T-cell large granulocyte leukemia. Amelioration by cladribine therapy. Chest 1997; 112: 551-553. (Pubitemid 27349454)
8. Howard LS, Chatterji S, Morrell NW, et al. Large granular lymphocyte leukaemia: a curable form of pulmonary arterial hypertension. Hosp Med 2005; 66: 364-365.
9. Sitbon O, Humbert M, Nunes H, et al. Long term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002; 40: 7880-7888.